Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
49.9M
-
Shares change
-
+49.9M
-
Total reported value, excl. options
-
$621M
-
Value change
-
+$621M
-
Number of buys
-
52
-
Price
-
$12.44
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2016
52 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q4 2016.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.9M shares
.
Largest 10 shareholders include QVT Financial LP (37.2M shares), BB BIOTECH AG (3.19M shares), RA CAPITAL MANAGEMENT, LLC (1.5M shares), DEERFIELD MANAGEMENT CO (1.5M shares), SCOPIA CAPITAL MANAGEMENT LP (818K shares), NORGES BANK (785K shares), BlackRock Advisors LLC (586K shares), GOLDMAN SACHS GROUP INC (465K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (450K shares), and Tekla Capital Management LLC (400K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.